Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             119 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats Wei, Xiao-Li
 2007
 17 Supplement 1 p. 790-799
10 p.
 artikel
2 Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive–compulsive disorder: A meta-analysis of the randomized controlled trials Skapinakis, Petros
 2007
 17 Supplement 1 p. 79-93
15 p.
 artikel
3 Association of the serotonin transporter promotor polymorphism with suicide attempters with a high medical damage Wasserman, Danuta
 2007
 17 Supplement 1 p. 230-233
4 p.
 artikel
4 Author Index 2007
 17 Supplement 1 p. S613-S630
18 p.
 artikel
5 Calendar of Events 2007
 17 Supplement 1 p. 234-
1 p.
 artikel
6 C.15.02 Bipolar disorder: clinical case studies Goikolea, J.M.
 2007
 17 Supplement 1 p. S607-
1 p.
 artikel
7 C.09.02 How existing treatments have helped patients and their current limitations – efficacy Conley, R.
 2007
 17 Supplement 1 p. S603-
1 p.
 artikel
8 C.21.01 Metabolic health issues in patients with schizophrenia Correll, C.U.
 2007
 17 Supplement 1 p. S612-
1 p.
 artikel
9 C.06.03 Switch and augmentation strategies in antipsychotic treatment: What can we learn from trials and patient cases? Nielsen, J.
 2007
 17 Supplement 1 p. S601-S602
2 p.
 artikel
10 C.02.02 The role of the reproductive hormones in mood disorders Blier, P.
 2007
 17 Supplement 1 p. S596-S597
2 p.
 artikel
11 ECNP Calendar of Events 2007
 17 Supplement 1 p. I-
1 p.
 artikel
12 Editorial Board 2007
 17 Supplement 1 p. CO2-
1 p.
 artikel
13 Editorial Board 2007
 17 Supplement 1 p. CO2-
1 p.
 artikel
14 Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat Abumaria, Nashat
 2007
 17 Supplement 1 p. 417-429
13 p.
 artikel
15 Effects of neurosteroids on glucocorticoid receptor-mediated gene transcription in LMCAT cells—A possible interaction with psychotropic drugs Basta-Kaim, Agnieszka
 2007
 17 Supplement 1 p. 37-45
9 p.
 artikel
16 Effects of the 5-HT1B receptor antagonist NAS-181 on extracellular levels of acetylcholine, glutamate and GABA in the frontal cortex and ventral hippocampus of awake rats: A microdialysis study Hu, Xiao Jing
 2007
 17 Supplement 1 p. 580-586
7 p.
 artikel
17 Effects of the novel 5-HT6 receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating Schreiber, Rudy
 2007
 17 Supplement 1 p. 277-288
12 p.
 artikel
18 E.04.03 The impact of publicly-funded vs. industry-funded AD trials on clinical practice Schneider, L.S.
 2007
 17 Supplement 1 p. S223-S224
2 p.
 artikel
19 GABAA receptors of hippocampal CA1 regions are involved in the acquisition and expression of morphine-induced place preference Rezayof, Ameneh
 2007
 17 Supplement 1 p. 24-31
8 p.
 artikel
20 Involvement of IL-1β in acute stress-induced worsening of cerebral ischaemia in rats Caso, Javier R.
 2007
 17 Supplement 1 p. 600-607
8 p.
 artikel
21 Modification of formalin-induced nociception by different histamine receptor agonists and antagonists Farzin, Davood
 2007
 17 Supplement 1 p. 122-128
7 p.
 artikel
22 Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function Gobbi, Gabriella
 2007
 17 Supplement 1 p. 328-338
11 p.
 artikel
23 P.6.a.011 Alcohol use disorder patients in a psychiatric unit: differential traits focussing on psychiatric comorbidity Mateu, G.
 2007
 17 Supplement 1 p. S544-S545
2 p.
 artikel
24 P.1.10 A complex norepinephrine and glucocorticoid intercellular interaction: relevance to plasticity hypothesis of depression Yaniv, S.P.
 2007
 17 Supplement 1 p. S10-S11
2 p.
 artikel
25 P.1.a.007 Decision-making behaviour is influenced by tryptophan hydroxylase 2 gene Juhasz, G.
 2007
 17 Supplement 1 p. S231-
1 p.
 artikel
26 P.1.38 Adjuvant treatment with the anticonvulsant drug topiramate in schizophrenia Konradsson, A.
 2007
 17 Supplement 1 p. S33-S34
2 p.
 artikel
27 P.1.41 β2-adrenoceptor activation induces expression of IL-1ra and the IL-1R(II) in vivo: implications for CNS inflammation Mc Namee, E.N.
 2007
 17 Supplement 1 p. S35-S36
2 p.
 artikel
28 P.5.a.001 Effect of functional diet Polygala tenuifolia Willdenow extract (BT-11) on memory function of healthy general population Jung, H.
 2007
 17 Supplement 1 p. S526-
1 p.
 artikel
29 P.8.a.023 HLA typing, CSF hypocretin-1 and MSLT for the diagnosis of narcolepsy and idiopathic hypersomnia in 121 Korean patients Hong, S.C.
 2007
 17 Supplement 1 p. S593-
1 p.
 artikel
30 P.3.a.006 Increased pituitary volume is a familial risk factor for schizophrenia but not for bipolar disorder Mondelli, V.
 2007
 17 Supplement 1 p. S404-S405
2 p.
 artikel
31 P.2.a.018 Lack of the large aftereffect of bright light on pupillary fluctuations in patients with non-seasonal depression Tokaji, Z.
 2007
 17 Supplement 1 p. S322-
1 p.
 artikel
32 P.3.a.023 Monotherapy and combination therapy of schizoaffective disorder, depressive type Izakova, L.
 2007
 17 Supplement 1 p. S414-
1 p.
 artikel
33 P.1.a.015 Neuregulin-1 risk haplotype and eye movements in schizophrenia Haraldsson, M.
 2007
 17 Supplement 1 p. S235-S236
2 p.
 artikel
34 P.4.a.004 Panic disorder and photosensitivity Bossini, L.
 2007
 17 Supplement 1 p. S502-
1 p.
 artikel
35 P.4.a.001 Sleep disorders and obsessive-compulsive disorder Drummond, L.M.
 2007
 17 Supplement 1 p. S500-S501
2 p.
 artikel
36 P.2.a.032 Sleep disturbance and suicidal ideation among college students Sonawalla, S.
 2007
 17 Supplement 1 p. S330-
1 p.
 artikel
37 P.2.a.015 Sleep disturbance in depression: results from a UK survey Paterson, L.M.
 2007
 17 Supplement 1 p. S320-
1 p.
 artikel
38 P.3.a.020 Sociodemographic and clinical characteristics of perinatal psychosis Vladimirova, R.
 2007
 17 Supplement 1 p. S412-S413
2 p.
 artikel
39 P.8.a.013 Therapeutic adhesion and suicide over a 8 year of follow-up in first psychotic episodes Uribe, F.
 2007
 17 Supplement 1 p. S587-
1 p.
 artikel
40 P.2.a.001 The role of valproate-induced hyperammonemia in suicidal patients: case series Ait-Daoud, N.
 2007
 17 Supplement 1 p. S312-
1 p.
 artikel
41 P.1.b.003 Anticonvulsive drug kinetic in patients with alcoholism Shushpanova, T.
 2007
 17 Supplement 1 p. S241-
1 p.
 artikel
42 P.2.b.011 Antidepressant therapy and apoptosis of immnocompetent cells in patients with depressive disorders Vyalova, N.
 2007
 17 Supplement 1 p. S338-
1 p.
 artikel
43 P.7.b.004 Anti-S100 antibodies modulate locomotor activity and exploratory behaviour of immature rats Dugina, J.L.
 2007
 17 Supplement 1 p. S571-
1 p.
 artikel
44 P.4.b.002 Brain biochemistry markers differentiate between animal models of anxiety and depression Math´e, A.A.
 2007
 17 Supplement 1 p. S510-S511
2 p.
 artikel
45 P.3.b.009 Enhanced amphetamine-induced dopamine release in rat nucleus accumbens following subchronic elevation of kynurenic acid Andersson, L.A.
 2007
 17 Supplement 1 p. S422-S423
2 p.
 artikel
46 P.2.b.014 Extracellular serotonin levels and expression of neurotrophic factors in rats with high or low novelty-related activity Harro, J.
 2007
 17 Supplement 1 p. S340-
1 p.
 artikel
47 P.3.b.010 Insulin-like growth factor 1 and recent onset schizophrenia Huizer, K.
 2007
 17 Supplement 1 p. S423-
1 p.
 artikel
48 P.5.b.005 Vesicular glutamate transporters in pathologies of the central nervous system Lepicard, E.
 2007
 17 Supplement 1 p. S534-
1 p.
 artikel
49 P.3.c.060 Acute effects of the ampakine farampator on memory and information processing in side effects free elderly volunteers Wezenberg, E.
 2007
 17 Supplement 1 p. S459-
1 p.
 artikel
50 P.1.c.047 Asenapine: long-term and dose-dependent effects on adrenergic and muscarinic cholinergic receptors in rat brain Shahid, M.
 2007
 17 Supplement 1 p. S269-S270
2 p.
 artikel
51 P.3.c.024 Differences of plasma BDNF, β-NGF, and IGF-1 between responder and non-responder in schizophrenic patients Lee, B.H.
 2007
 17 Supplement 1 p. S437-S438
2 p.
 artikel
52 P.1.c.013 Differential expression of BDNF mRNA in brain of rat after chronic lithium treatment Noh, J.S.
 2007
 17 Supplement 1 p. S249-
1 p.
 artikel
53 P.3.c.029 Effectiveness of switching from risperidone to amisulpride in stabilized schizophrenic patients with depression Kim, S.W.
 2007
 17 Supplement 1 p. S440-S441
2 p.
 artikel
54 P.3.c.046 Effect of long-acting injectable antipsychotics on patient contact with services and polypharmacy Naidoo, K.S.
 2007
 17 Supplement 1 p. S451-
1 p.
 artikel
55 P.3.c.073 Effects of asenapine on cognitive function in acute schizophrenia: a placebo- and risperidone-controlled trial Fleming, K.
 2007
 17 Supplement 1 p. S466-S467
2 p.
 artikel
56 P.3.c.015 Effects of the atypical antipsychotic clozapine on insulin release in vitro Melkersson, K.
 2007
 17 Supplement 1 p. S432-
1 p.
 artikel
57 P.7.c.003 Escitalopram plus levetiracetam and spontaneous orgasms in an female adolescent: a case report Ruiz-Lazaro, P.M.
 2007
 17 Supplement 1 p. S573-
1 p.
 artikel
58 P.3.c.070 Factors associated with obesity in schizophrenia: baseline results from the French ESPASS survey Rouillon, F.
 2007
 17 Supplement 1 p. S464-S465
2 p.
 artikel
59 P.2.28 Chronic imipramine treatment partly reverses behavioral effects of social defeat in rats Galankin, T.
 2007
 17 Supplement 1 p. S61-S62
2 p.
 artikel
60 P.1.c.044 Improvement of AMPA antagonist activity by methyl substitution on the aniline ring of 2,3-benzodiazepine derivatives Kertesz, S.
 2007
 17 Supplement 1 p. S267-S268
2 p.
 artikel
61 P.3.c.012 Intramuscular and orodispersable olanzapine efficiency in the acute treatment of manic episodes Vasile, D.
 2007
 17 Supplement 1 p. S430-S431
2 p.
 artikel
62 P.2.c.038 Long-term efficacy of agomelatine, a novel antidepressant, in the prevention of relapse in out-patients with major depressive disorder Goodwin, G.M.
 2007
 17 Supplement 1 p. S361-S362
2 p.
 artikel
63 P.2.c.009 Mirtazapine for the rapid control of nausea and insomnia in cancer patients with depression Kim, S.W.
 2007
 17 Supplement 1 p. S346-
1 p.
 artikel
64 P.2.c.023 Switching to duloxetine from SSRI non- and partial-responders: does the type of SSRI prior to switch influence outcomes? Perahia, D.
 2007
 17 Supplement 1 p. S353-S354
2 p.
 artikel
65 P.1.c.030 Synergistic interaction between gabapentin and oxcarbazepine in a mouse model of painful diabetic neuropathy Tomic, M.
 2007
 17 Supplement 1 p. S259-
1 p.
 artikel
66 P.3.c.016 The relation between insulin receptor substrate-1 gene and olanzapine-induced weight gain and smoking in schizophrenia patients Sengul, C.
 2007
 17 Supplement 1 p. S433-
1 p.
 artikel
67 P.1.c.016 URB597, fatty acid amide hydrolase inhibitor, improves long-term memory retention by PPARalpha and not by cannabinoid CB1 receptors Mazzola, C.
 2007
 17 Supplement 1 p. S251-
1 p.
 artikel
68 P.3.d.003 Antipsychotic prescription patterns among psychiatrists at state hospital in Turkey Karamustafalioglu, O.
 2007
 17 Supplement 1 p. S474-S475
2 p.
 artikel
69 P.2.d.017 Behavioral and molecular effects of repeated treatment with citalopram alone or combined with memantine in rats Tamburella, A.
 2007
 17 Supplement 1 p. S371-
1 p.
 artikel
70 P.3.d.020 CAM24, a D3/5HT2a/5HT1a ligand reduces psychostimulant induced hyperactivity in mice without causing motor side effects Sandager-Nielsen, K.
 2007
 17 Supplement 1 p. S484-S485
2 p.
 artikel
71 P.2.d.003 Effect of tramadol on corticosteroid receptor function in patients with major depression Minenko, S.
 2007
 17 Supplement 1 p. S363-S364
2 p.
 artikel
72 P.1.d.008 Effects on the adult behavioral changes of early maternal separation during the stage of development in the rat Chung, Y.
 2007
 17 Supplement 1 p. S277-S278
2 p.
 artikel
73 P.5.d.001 Expression of alpha-synuclein in patients with Parkinson's disease caused by mutations in the LRRK2 gene Pchelina, S.
 2007
 17 Supplement 1 p. S536-
1 p.
 artikel
74 P.3.d.016 Homer 1 and metabotropic glutamate- receptor 5 polymorphisms are associated with response to treatment in schizophrenia Musil, R.
 2007
 17 Supplement 1 p. S482-S483
2 p.
 artikel
75 P.3.09 Differential effect of citalopram and reboxetine on cortical glutamate as measured by proton magnetic resonance spectroscopy Selvaraj, S.
 2007
 17 Supplement 1 p. S76-S77
2 p.
 artikel
76 P.1.002 Do repeated tacrine applications induce smooth muscle desensitization in rats? Prisadova, N.
 2007
 17 Supplement 1 p. S148-
1 p.
 artikel
77 P.6.d.003 Smoking high potency marijuana: theta power correlates with memory search Böcker, K.B.E
 2007
 17 Supplement 1 p. S553-
1 p.
 artikel
78 P.3.d.017 The atypical and classical antypsychotic drugs affect adenosine diphosphate-induced platelet aggregation Dietrich-Muszalska, A.
 2007
 17 Supplement 1 p. S483-
1 p.
 artikel
79 P.6.d.006 The in vivo modulation of the mesolimbic dopamine system by cannabinoid CB1 receptors Cornish, J.L.
 2007
 17 Supplement 1 p. S555-
1 p.
 artikel
80 P.7.e.003 ADHD in children presenting sleep disorders Savvidou, M.
 2007
 17 Supplement 1 p. S579-
1 p.
 artikel
81 P.1.e.022 Anomalous cerebral asymmetry in patients with schizophrenia demonstrated by voxel-based morphometry Kawasaki, Y.
 2007
 17 Supplement 1 p. S293-
1 p.
 artikel
82 P.3.e.011 Clinical outcome and predictors for the efficacy of electroconvulsive therapy: a retrospective chart review Choi, E.Y.
 2007
 17 Supplement 1 p. S492-S493
2 p.
 artikel
83 P.1.005 Effects of Tyr-W-MIF-1 on nociception after stress: influence on nitric oxide-ergic system Bocheva, A.I.
 2007
 17 Supplement 1 p. S150-S151
2 p.
 artikel
84 P.1.004 Effects of Tyr-W-MIF-1 on the opioidergic system and methylene blue after stress Bocheva, A.I.
 2007
 17 Supplement 1 p. S149-S150
2 p.
 artikel
85 P.1.24 Epigenetic factors in the vulnerability to post-traumatic stress disorder;the role of DNA methylation Chertkow-Deutsher, Y.
 2007
 17 Supplement 1 p. S21-S22
2 p.
 artikel
86 P.2.e.008 Searching susceptibility loci for mania: a sib pairs pilot study Pirovano, A.
 2007
 17 Supplement 1 p. S380-S381
2 p.
 artikel
87 P.1.e.019 Size, FDG-PET activity, and neuroleptic responsivity of the medialdorsal nucleus of the thalamus in schizophrenia Buchsbaum, M.
 2007
 17 Supplement 1 p. S291-S292
2 p.
 artikel
88 P.6.e.009 Suicidal behaviour and abuse of psychoactive substance at urgent psychiatry outpatients department Zmuc Veranic, L.
 2007
 17 Supplement 1 p. S563-
1 p.
 artikel
89 P.1.e.009 The neural correlates of reduced dopamine and serotonin in mood and reinforcement Lythe, K.E.
 2007
 17 Supplement 1 p. S285-S286
2 p.
 artikel
90 P.3.f.002 Effect of the selective glycine re-uptake (GlyT-1) inhibitor Org 25935 on glycine levels in CSF and dialysates Andrews, N.
 2007
 17 Supplement 1 p. S497-S498
2 p.
 artikel
91 P.2.f.005 Membrane phospholipid distribution: a comparison between patient with schizophrenia and bipolar disorder Tessier, C.
 2007
 17 Supplement 1 p. S390-S391
2 p.
 artikel
92 P.2.f.002 Olanzapine versus divalproex and placebo for the treatment of mild to moderate mania associated with bipolar I disorder Tohen, M.
 2007
 17 Supplement 1 p. S388-S389
2 p.
 artikel
93 P.1.f.010 Personality assessment inventory of psychiatric patients – psychometric compatibility and clinical applicability Park, M.
 2007
 17 Supplement 1 p. S302-
1 p.
 artikel
94 P.3.19 Functional imaging of rumination on task failure Pegg, E.
 2007
 17 Supplement 1 p. S84-S85
2 p.
 artikel
95 P.2.11 Galanin and depression-like behaviour in the rat Kuteeva, E.
 2007
 17 Supplement 1 p. S48-S49
2 p.
 artikel
96 P.3.06 High-frequency repetitive transcranial magnetic stimulation and its influence on negative symptoms of schizophrenia Ustohal, L.
 2007
 17 Supplement 1 p. S74-
1 p.
 artikel
97 P.2.h.002 Paroxetine effects on emotions: a 4-week randomized placebo-controlled pilot study in psychologists and psychiatrists Cass´e-Perrot, C.
 2007
 17 Supplement 1 p. S398-S399
2 p.
 artikel
98 P.1.07 Methylenetetrahydrofolate reductase gene and unipolar depression: focus on personality traits Gaysina, D.
 2007
 17 Supplement 1 p. S7-S8
2 p.
 artikel
99 P.1.05 Neuron and forebrain specific deletion of the glycine transporter 1 gene enhances spontaneous object recognition memory Singer, P.
 2007
 17 Supplement 1 p. S6-
1 p.
 artikel
100 P.8.002 Quality of life in patients with colorectal cancer one year after surgery Karadjova, D.
 2007
 17 Supplement 1 p. S166-
1 p.
 artikel
101 P.1.37 Regulation of microsomal prostaglandin E synthase-1 (mPGES-1) expression in activated primary rat microglia Oliveira, A.C.P.
 2007
 17 Supplement 1 p. S32-S33
2 p.
 artikel
102 P.1.04 Serotonin transporter dependent effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) on the serotoninergic system and hippocampal cell proliferation in mice Renoir, T.
 2007
 17 Supplement 1 p. S5-S6
2 p.
 artikel
103 Psychological and cytokine changes in children and adolescents undergoing hematopoietic stem cell transplantation Munitz-Shenkar, Dafna
 2007
 17 Supplement 1 p. 58-63
6 p.
 artikel
104 P.8.005 The acute effects of modafinil on mood, self-assessment, driving simulator performance, and neuropsychological performance following sleep deprivation Gurtman, C.
 2007
 17 Supplement 1 p. S168-
1 p.
 artikel
105 P.2.007 The safety of selective serotonin reuptake inhibitors in pregnancy – a preclinical and clinical data review Pendicheva, D.I.
 2007
 17 Supplement 1 p. S157-S158
2 p.
 artikel
106 S.23.01 Cardiovascular reflexes: physiological and pathophysiological influences from the brain Sevoz-Couche, C.
 2007
 17 Supplement 1 p. S211-
1 p.
 artikel
107 S.10.04 European guidelines: efficacy of immediate release and long-acting medication Banaschewski, T.
 2007
 17 Supplement 1 p. S193-
1 p.
 artikel
108 S.02.04 Glutamate modulators in treatment resistant depression Zarate, C.
 2007
 17 Supplement 1 p. S177-S178
2 p.
 artikel
109 S.07.07 Increased opioid receptor binding in early abstinence from dependent opioid and alcohol use and relationship to craving Williams, T.M.
 2007
 17 Supplement 1 p. S187-S188
2 p.
 artikel
110 S.27.01 Mapping brain maturation and cognitive development during adolescence Paus, T.
 2007
 17 Supplement 1 p. S217-
1 p.
 artikel
111 S.26.02 MDMA facilitated treatment of PTSD Mithoefer, M.
 2007
 17 Supplement 1 p. S216-
1 p.
 artikel
112 S.04.03 Neuron and forebrain specific deletion of the glycine transporter 1 gene enhances spontaneous object recognition memory Singer, P.
 2007
 17 Supplement 1 p. S180-S181
2 p.
 artikel
113 S.06.01 Non-cognitive and behavioural symptoms in Alzheimer's disease Dal Forno, G.
 2007
 17 Supplement 1 p. S183-S184
2 p.
 artikel
114 S.04.04 Objective monitoring of antipsychotic treatment Haralanov, S.H.
 2007
 17 Supplement 1 p. S143-
1 p.
 artikel
115 S.19.05 Paradigm shift in Alzheimer's disease: intraneuronal Ab aggregation triggers neuron loss Bayer, T.A.
 2007
 17 Supplement 1 p. S205-S206
2 p.
 artikel
116 S.16.02 Rewarding properties of MDMA – behaviour and underlying mechanisms Robledo, P.
 2007
 17 Supplement 1 p. S199-
1 p.
 artikel
117 S.19.02 Sporadic and familial cerebral amyloid angiopathies Revesz, T.
 2007
 17 Supplement 1 p. S204-S205
2 p.
 artikel
118 S.11.02 Validation of CO2 stress test in humans Nutt, D.
 2007
 17 Supplement 1 p. S194-
1 p.
 artikel
119 The progesterone metabolite allopregnanolone potentiates GABAA receptor-mediated inhibition of 5-HT neuronal activity Kaura, Vikas
 2007
 17 Supplement 1 p. 108-115
8 p.
 artikel
                             119 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland